Brain Stimulation for Improving Working Memory
(TravelingTES Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how transcranial alternating current stimulation (tACS), a type of brain stimulation, might improve working memory. It uses low-level electrical currents on specific brain areas to test if memory skills can be enhanced. Researchers are testing four different stimulation techniques. This trial may suit adults who are fluent in English and have no neurological conditions or head injuries. As an unphased trial, it offers a unique opportunity to contribute to cutting-edge research in brain stimulation and memory enhancement.
Do I have to stop taking my current medications?
Yes, you must stop taking your current medications because the trial excludes anyone with a medical condition that requires ongoing pharmacological treatment.
Will I have to stop taking my current medications?
Yes, you will need to stop taking your current medications, as the trial excludes anyone with a medical condition that requires ongoing treatment with drugs.
What prior data suggests that transcranial alternating current stimulation (tACS) is safe for improving working memory?
Research has shown that transcranial alternating current stimulation (tACS) is generally safe and well-tolerated. In a study involving young people with a specific genetic condition, participants tolerated tACS well, experiencing no major problems during treatment. Another review highlighted that tACS is safer compared to other similar methods, making it a promising option for boosting brain function. These findings suggest that tACS is a safe treatment option for improving working memory in adults.12345
Why are researchers excited about this trial's treatments?
Researchers are excited about using transcranial alternating current stimulation (tACS) to improve working memory because it offers a non-invasive approach that directly targets brain regions involved in memory processing. Most traditional treatments rely on medications that affect neurotransmitter levels or cognitive training exercises. In contrast, tACS uses electrical currents to create specific brain wave patterns, like the parietofrontal or frontoparietal theta waves at different frequencies, which could enhance communication between brain areas critical for memory. This technique could provide a faster, more targeted way to boost cognitive function without the side effects associated with medication.
What evidence suggests that this trial's treatments could be effective for improving working memory?
Research has shown that transcranial alternating current stimulation (tACS) can improve working memory in healthy individuals. This trial will explore various types of tACS, including Parietofrontal Slow Theta Stimulation, Parietofrontal Fast Theta Stimulation, Frontoparietal Slow Theta Stimulation, and Frontoparietal Fast Theta Stimulation. Studies have found that real tACS, compared to a placebo, can sometimes enhance working memory, but results vary. Some studies discovered that a specific type, theta tACS, did not significantly improve working memory. The results depend on the exact frequency used and the targeted brain areas. Overall, while tACS shows promise, its effectiveness in boosting working memory is not guaranteed and can vary among individuals.46789
Who Is on the Research Team?
Ivan Alekseichuk, PhD
Principal Investigator
University of Minnesota
Are You a Good Fit for This Trial?
This trial is for adults aged 18-45 with a good grasp of English. It's not suitable for those with chronic neurological or mental disorders, head injuries causing unconsciousness, ongoing medical conditions needing drugs, pregnant or breastfeeding individuals, substance addicts, or people with metal/electric implants in the upper body.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive transcranial alternating current stimulation (tACS) to assess its impact on working memory performance
Follow-up
Participants are monitored for changes in EEG connectivity and reaction time post-stimulation
What Are the Treatments Tested in This Trial?
Interventions
- Transcranial Alternating Current Stimulation (tACS)
Trial Overview
The study is testing how traveling-wave transcranial electric stimulation (tACS), a non-invasive brain stimulation technique, affects working memory performance in healthy adults.
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Participants will receive multi-electrode transcranial alternating current stimulation over the prefrontal and parietal brain regions that induces parietal-to-frontal traveling wave at the frequency of 4 Hz with the intensity of up to 2 mA and duration up to 20 min.
Participants will receive multi-electrode transcranial alternating current stimulation over the prefrontal and parietal brain regions that induces parietal-to-frontal traveling wave at the frequency of 7 Hz with the intensity of up to 2 mA and duration up to 20 min.
Participants will receive multi-electrode transcranial alternating current stimulation over the prefrontal and parietal brain regions that induces frontal-to-parietal traveling wave at the frequency of 4 Hz with the intensity of up to 2 mA and duration up to 20 min.
Participants will receive multi-electrode transcranial alternating current stimulation over the prefrontal and parietal brain regions that induces frontal-to-parietal traveling wave at the frequency of 7 Hz with the intensity of up to 2 mA and duration up to 20 min.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
Brain & Behavior Research Foundation
Collaborator
Published Research Related to This Trial
Citations
1.
frontiersin.org
frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2023.1265600/fullFronto-parietal theta high-definition transcranial alternating ...
This study aimed to investigate the immediate effects of fronto-parietal θ HD-tACS on a dual task of working memory-postural control.
Theta transcranial alternating current stimulation is not ...
Taken together, our results demonstrate that theta frequency tACS applied at the midline is not an effective method for enhancing WM.
A meta-analysis showing improved cognitive performance ...
This systematic review and meta-analysis investigated the effects of tACS protocols on cognitive functions in healthy young adults.
Effect of theta-transcranial alternating current stimulation ...
Core Tip: In this meta-analysis, we evaluated theta-band transcranial alternating current stimulation for working memory enhancement in healthy adults. Although ...
Efficacy of Transcranial Alternating Current Stimulation in ...
Active tACS enhances working memory performance in healthy individuals compared to sham, with a moderate effect size (Cohen’s d = 0.5).
A randomized double-blind sham-controlled study
Transcranial alternating current stimulation (tACS) was well-tolerated among young individuals with 22q11.2 deletion syndrome (22q11.2DS).
Working Memory and Transcranial-Alternating Current ...
Compared to rTMS, tACS demonstrates superior cost, tolerability, portability, and safety profile, making it an attractive potential tool for ...
8.
translationalneurodegeneration.biomedcentral.com
translationalneurodegeneration.biomedcentral.com/articles/10.1186/s40035-024-00423-yTranscranial alternating current stimulation (tACS) at gamma ...
We outline the current knowledge concerning the clinical efficacy, safety, ease-of-use and cost-effectiveness of tACS on early and advanced AD.
Efficacy of tACS in the enhancement of working memory ...
In contrast, transcranial alternating current stimulation (tACS) is a form of NIBS that safely and painlessly alters cortical oscillations, rhythmic patterns of ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.